Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 11/20 | 0.45 |
| ▸ | CA2 | P00918 | 11/20 | 0.45 |
| ▸ | CA9 | Q16790 | 11/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 11/20 | 0.45 |
| ▸ | DRD1 | P21728 | 3/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | DRD5 | P21918 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL986382 | 0.92 | CA1 (0.48) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL986893 | 0.91 | CA1 (0.41) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL985807 | 0.91 | TSHR (0.47) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL987287 | 0.85 | CA1 (0.52) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL988435 | 0.83 | CA1 (0.45) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL986403 | 0.83 | DRD1 (0.52) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL987212 | 0.83 | PARP1 (0.39) | DRD1DRD2DRD4DRD5DRD3 | |
| SCHEMBL983323 | 0.82 | CA1 (0.47) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL4669565 | 0.80 | TSHR (0.53) | CA1CA2CA9CA14DRD1 | |
| SCHEMBL983857 | 0.80 | CA1 (0.52) | CA1CA2CA9CA14DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1732898-B1 | TETRAHYDROISOQUINOLINE- AND TETRAHYDROBENZAZEPINE DERIVATIVES AS IGF-1R INHIBITORS | ANALYTECON SA (CH) | 2008-01-23 | — | — | EP | claimed |